Evidence map›Paper›PMID 39493809›Full record

ArticleMaterials today. Bio2024

Intelligent nanocatalyst mediated lysosomal ablation pathway to coordinate the amplification of tumor treatment.

Mingliang Pei, Xin Guan, De Zhao, Fan Yang, Yun Dong, Manxiu Huai, Wensong Ge, Xiaodong Hou, Wenfeng Chu, Kai Wang and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Materials today. Bio, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Mingliang PeiDepartment of Medical Ultrasound and Center of Minimally Invasive Treatment for Tumor, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, No. 301 Yan-chang-zhong Road, Shanghai, 200072, PR China.
Xin GuanDepartment of Ultrasound, Zhongshan Hospital, Institute of Ultrasound in Medicine and Engineering, Fudan University, Shanghai, 200032, PR China.
De ZhaoKey Laboratory for Translational Research and Innovative Therapeutics of Gastrointestinal Oncology, Hongqiao International Institute of Medicine, Department of Gastroenterology, Shanghai Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200336, PR China.
Fan YangDepartment of Orthopaedics, Shanghai Key Laboratory for Prevention and Treatment of Bone and Joint Diseases, Shanghai Institute of Traumatology and Orthopaedics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, PR China.
Yun DongShanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, No.241 West Huaihai Road, Shanghai, 200030, PR China.
Manxiu HuaiDepartment of Gastroenterology, Xinhua Hospital, Shanghai Jiaotong University, School of Medicine. No. 1665 Kongjiang Road, Shanghai, 200092, PR China.
Wensong GeDepartment of Gastroenterology, Xinhua Hospital, Shanghai Jiaotong University, School of Medicine. No. 1665 Kongjiang Road, Shanghai, 200092, PR China.
Xiaodong HouDepartment of Medical Ultrasound and Center of Minimally Invasive Treatment for Tumor, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, No. 301 Yan-chang-zhong Road, Shanghai, 200072, PR China.
Wenfeng ChuDepartment of Gastroenterology, Xinhua Hospital, Shanghai Jiaotong University, School of Medicine. No. 1665 Kongjiang Road, Shanghai, 200092, PR China.
Kai WangShanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, No.241 West Huaihai Road, Shanghai, 200030, PR China.
Jie ChenShanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, No.241 West Huaihai Road, Shanghai, 200030, PR China.
Huixiong XuDepartment of Ultrasound, Zhongshan Hospital, Institute of Ultrasound in Medicine and Engineering, Fudan University, Shanghai, 200032, PR China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The production of reactive oxygen species (ROS) is susceptible to external excitation or insufficient supply of related participants (

Indexed as

Lysosomal damnificationpH-unlocked 1O2 generationProgrammed ROS strategyTumor therapy

Identifiers

PMID39493809
PMCPMC11530759

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.